·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® ±â»çÀÔ·Â : 23.01.17 19:26:21 5 °¡ ÇÃÄ£Ãß°¡ ÇÕ°Ý·ü 87%...ÃÖ±Ù 5³â Áß ÇÕ°Ý·ü¡¤ÇÕ°ÝÀÚ¼ö ÃÖ°í [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇѾà»ç 134¸íÀÌ ¿ÃÇØ ±¹°¡½ÃÇè¿¡ ÇÕ°ÝÇÏ¸ç ½Å±Ô ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³ 6ÀÏ ½ÃÇàµÈ Á¦24ȸ ÇѾà»ç ±¹°¡½ÃÇèÀÇ ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀº Àüü 154¸íÀÇ ÀÀ½ÃÀÚ Áß 134¸íÀÌ ÇÕ°ÝÇØ 87%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù 5³â°£ ÇѾà»ç ±¹°¡½ÃÇè Áß °¡Àå ³ôÀº ÇÕ°Ý·üÀ» º¸¿´´Ù. ÇÕ°ÝÀÚ¼öµµ °¡Àå ¸¹´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀÇ ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 229Á¡(91.6Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ì¼®´ëÇб³ ½Åȣö¾¾°¡ Â÷ÁöÇß´Ù. ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ ÇÕ°Ý ¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ¤·¤· ÃàÇÏ ¸Å¾à Àü¹® ¾à±¹¼ö°¡ 130°³ ´Ã¾î³µ½À´Ï´Ù ÃàÇϵ帳´Ï´Ù 10³âÈÄ 1300 °³ ¾à±¹ÀÌ ´õ ´Ã¾î³ª³×¿ä ÃàÇϵ帳´Ï´Ù 23.01.18 21:16:33 1 ¼öÁ¤ »èÁ¦ 6 1 À½ . Àǻ籹½Ã ÇÕ°ÝÀÚ´Â 3õ¸íÀÌ ³Ñ´Â´Ù. ÀϹÝÀÇ µÇ±â°¡ ¹«Áö ½¬¿î°©´Ù. 23.01.18 16:50:26 0 ¼öÁ¤ »èÁ¦ 1 0 ?? µ¥Àϸ®ÆÊ¿¡ ÇѾà»ç ¼Ò½ÄÀ» ¿Ö ÆÛ³ª¸£´Â°Å¾ß? µ¥Àϸ®ÆÊ ÀÌ»õ±âµéÀÌ Á¦ÀÏ ¾ÇÁúÀÌ³× 23.01.18 11:01:37 0 ¼öÁ¤ »èÁ¦ 7 23 ±è³²¼÷ ¿ª½Ã ¿Àºü°¡ ¯À̾ß!!!³Ê¹«³Ê¹« ÃàÇÏÇØ~~~!!!!! ÃàÇÏÇØ~~ 23.01.18 10:30:23 0 ¼öÁ¤ »èÁ¦ 7 6 ¤·¤· ÃàÇÏÇÕ´Ï´Ù °í»ýÇϼ̽À´Ï´Ù 23.01.18 01:07:37 0 ¼öÁ¤ »èÁ¦ 14 13 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® ±â»çÀÔ·Â : 23.01.17 19:26:21 5 °¡ ÇÃÄ£Ãß°¡ ÇÕ°Ý·ü 87%...ÃÖ±Ù 5³â Áß ÇÕ°Ý·ü¡¤ÇÕ°ÝÀÚ¼ö ÃÖ°í [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇѾà»ç 134¸íÀÌ ¿ÃÇØ ±¹°¡½ÃÇè¿¡ ÇÕ°ÝÇÏ¸ç ½Å±Ô ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³ 6ÀÏ ½ÃÇàµÈ Á¦24ȸ ÇѾà»ç ±¹°¡½ÃÇèÀÇ ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀº Àüü 154¸íÀÇ ÀÀ½ÃÀÚ Áß 134¸íÀÌ ÇÕ°ÝÇØ 87%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù 5³â°£ ÇѾà»ç ±¹°¡½ÃÇè Áß °¡Àå ³ôÀº ÇÕ°Ý·üÀ» º¸¿´´Ù. ÇÕ°ÝÀÚ¼öµµ °¡Àå ¸¹´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀÇ ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 229Á¡(91.6Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ì¼®´ëÇб³ ½Åȣö¾¾°¡ Â÷ÁöÇß´Ù. ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ ÇÕ°Ý ¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ¤·¤· ÃàÇÏ ¸Å¾à Àü¹® ¾à±¹¼ö°¡ 130°³ ´Ã¾î³µ½À´Ï´Ù ÃàÇϵ帳´Ï´Ù 10³âÈÄ 1300 °³ ¾à±¹ÀÌ ´õ ´Ã¾î³ª³×¿ä ÃàÇϵ帳´Ï´Ù 23.01.18 21:16:33 1 ¼öÁ¤ »èÁ¦ 6 1 À½ . Àǻ籹½Ã ÇÕ°ÝÀÚ´Â 3õ¸íÀÌ ³Ñ´Â´Ù. ÀϹÝÀÇ µÇ±â°¡ ¹«Áö ½¬¿î°©´Ù. 23.01.18 16:50:26 0 ¼öÁ¤ »èÁ¦ 1 0 ?? µ¥Àϸ®ÆÊ¿¡ ÇѾà»ç ¼Ò½ÄÀ» ¿Ö ÆÛ³ª¸£´Â°Å¾ß? µ¥Àϸ®ÆÊ ÀÌ»õ±âµéÀÌ Á¦ÀÏ ¾ÇÁúÀÌ³× 23.01.18 11:01:37 0 ¼öÁ¤ »èÁ¦ 7 23 ±è³²¼÷ ¿ª½Ã ¿Àºü°¡ ¯À̾ß!!!³Ê¹«³Ê¹« ÃàÇÏÇØ~~~!!!!! ÃàÇÏÇØ~~ 23.01.18 10:30:23 0 ¼öÁ¤ »èÁ¦ 7 6 ¤·¤· ÃàÇÏÇÕ´Ï´Ù °í»ýÇϼ̽À´Ï´Ù 23.01.18 01:07:37 0 ¼öÁ¤ »èÁ¦ 14 13 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® ±â»çÀÔ·Â : 23.01.17 19:26:21 5 °¡ ÇÃÄ£Ãß°¡ ÇÕ°Ý·ü 87%...ÃÖ±Ù 5³â Áß ÇÕ°Ý·ü¡¤ÇÕ°ÝÀÚ¼ö ÃÖ°í [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇѾà»ç 134¸íÀÌ ¿ÃÇØ ±¹°¡½ÃÇè¿¡ ÇÕ°ÝÇÏ¸ç ½Å±Ô ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³ 6ÀÏ ½ÃÇàµÈ Á¦24ȸ ÇѾà»ç ±¹°¡½ÃÇèÀÇ ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀº Àüü 154¸íÀÇ ÀÀ½ÃÀÚ Áß 134¸íÀÌ ÇÕ°ÝÇØ 87%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù 5³â°£ ÇѾà»ç ±¹°¡½ÃÇè Áß °¡Àå ³ôÀº ÇÕ°Ý·üÀ» º¸¿´´Ù. ÇÕ°ÝÀÚ¼öµµ °¡Àå ¸¹´Ù. À̹ø ÇѾà»ç ±¹°¡½ÃÇèÀÇ ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 229Á¡(91.6Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ì¼®´ëÇб³ ½Åȣö¾¾°¡ Â÷ÁöÇß´Ù. ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ ÇÕ°Ý ¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
¤·¤· ÃàÇÏ ¸Å¾à Àü¹® ¾à±¹¼ö°¡ 130°³ ´Ã¾î³µ½À´Ï´Ù ÃàÇϵ帳´Ï´Ù 10³âÈÄ 1300 °³ ¾à±¹ÀÌ ´õ ´Ã¾î³ª³×¿ä ÃàÇϵ帳´Ï´Ù 23.01.18 21:16:33 1 ¼öÁ¤ »èÁ¦ 6 1 À½ . Àǻ籹½Ã ÇÕ°ÝÀÚ´Â 3õ¸íÀÌ ³Ñ´Â´Ù. ÀϹÝÀÇ µÇ±â°¡ ¹«Áö ½¬¿î°©´Ù. 23.01.18 16:50:26 0 ¼öÁ¤ »èÁ¦ 1 0 ?? µ¥Àϸ®ÆÊ¿¡ ÇѾà»ç ¼Ò½ÄÀ» ¿Ö ÆÛ³ª¸£´Â°Å¾ß? µ¥Àϸ®ÆÊ ÀÌ»õ±âµéÀÌ Á¦ÀÏ ¾ÇÁúÀÌ³× 23.01.18 11:01:37 0 ¼öÁ¤ »èÁ¦ 7 23 ±è³²¼÷ ¿ª½Ã ¿Àºü°¡ ¯À̾ß!!!³Ê¹«³Ê¹« ÃàÇÏÇØ~~~!!!!! ÃàÇÏÇØ~~ 23.01.18 10:30:23 0 ¼öÁ¤ »èÁ¦ 7 6 ¤·¤· ÃàÇÏÇÕ´Ï´Ù °í»ýÇϼ̽À´Ï´Ù 23.01.18 01:07:37 0 ¼öÁ¤ »èÁ¦ 14 13 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç ±¹½Ã 134¸í ÇÕ°Ý...¿ì¼®´ë ½Åȣö¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö